BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 12, 2013
View Archived Issues
Novel LM-Kras vaccine delays progression of pancreatic intraepithelial neoplasia in vivo
Read More
Potential new treatment for patients susceptible to lactic acidosis
Read More
Novel protein Wnt signaling inhibitors synthesized at Samumed
Read More
Development of novel ERK inhibitor SCH-772984 reported
Read More
Bayer presents BAY-ACC001 as a potent and selective AAC inhibitor
Read More
AstraZeneca reports on novel ATR inhibitor AZD-6738
Read More
New protein kinase inhibitors designed by Merck KGaA
Read More
Sanofi develops novel DGAT1 inhibitors for metabolic disorders
Read More
GR modulators show promise in models of respiratory diseases
Read More
Abbott obtains CE mark for galectin-3 heart failure test
Read More
Johns Hopkins University patents new chymase inhibitors
Read More
Sanofi Pasteur's quadrivalent influenza vaccine accepted for review in Europe
Read More
Quest Diagnostics launches new tests for rheumatoid arthritis
Read More
VereFlu detects current H7N9 avian flu subtype
Read More
Sarepta Therapeutics and UWA expand agreement for exon-skipping program
Read More
Lundbeck designs novel mGlu5 receptor allosteric modulators
Read More
Avioq launches Avioq HTLV-I/II test in Europe
Read More
Photocure reports final results from phase IIb study of Cevira
Read More
Gamida Cell reports results from final analyses of phase II/III study of StemEx
Read More
Novel NS5B inhibitors disclosed by Biota Scientific Management
Read More
Confirmatory phase III study not required for filing pimavanserin NDA
Read More
New CDK9/cyclin-T1 inhibitors divulged by Bayer Intellectual Property
Read More
Sarah Cannon Research Institute to conduct phase II study of OGX-427
Read More
First European launch for Jetrea in U.K.
Read More
Aptalis launches Pylera in France
Read More
FDA accepts Varisolve NDA for full review
Read More
